← Back to Search

Cognitive Behavioral Therapy for Leukemia and Lymphoma-related Fatigue

Q: Are there any open slots available to participate in this clinical experiment?

<p>The relevant page of clinicaltrials.gov discloses that this particular research is no longer recruiting patients, having first been posted on the 29th November 2018 and last updated on the 5th December 2022. However, at present there are 3269 other studies actively searching for participants.</p>

Q: Has the FDA accorded its blessing to the usage of Cognitive Behavioral Therapy (CBT) as a form of Supportive Care?

<p>Our company has evaluated the safety of Supportive Care (CBT) and assigned it a score of 2, since there are some studies supporting its security but none affirming its efficacy.</p>

Phase 2

Waitlist Available

Led By Sriram Yennu

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Able to communicate in English or Spanish.

Zubrod performance status =< 2.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 8 weeks or 6 months

Awards & highlights

Study Summary

This trialstudies how CBT helps leukemia/lymphoma patients manage fatigue. CBT uses methods to change thinking/action to cope with cancer-related fatigue, anxiety & depression.

Who is the study for?

This trial is for patients with acute myeloid leukemia or lymphoma who are experiencing cancer-related fatigue. They must have a performance status indicating they can carry out light activity, have had persistent fatigue for at least two weeks, and not be severely anemic. Participants should speak English or Spanish and haven't received cognitive behavioral therapy in the past year.Check my eligibility

What is being tested?

The study is testing whether cognitive behavioral therapy (CBT) can help reduce fatigue in patients with certain types of blood cancers. CBT aims to change thinking and behavior patterns that contribute to patients' anxiety, depression, and overall fatigue levels.See study design

What are the potential side effects?

Cognitive Behavioral Therapy generally does not cause physical side effects but may sometimes lead to emotional discomfort as individuals confront difficult thoughts and feelings during the process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can communicate in English or Spanish.

Select...

I can take care of myself but might not be able to do heavy physical work.

Select...

I have AML or AML from MDS and feel tired most of the time.

Select...

I have been feeling tired for at least two weeks.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 8 weeks or 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 8 weeks or 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 8 weeks or 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adherence to cognitive behavioral therapy (CBT) defined as percentage of the total completed prescribed counseling sessions (7 sessions) the study patient is able to complete

Satisfaction with CBT assessed using a 5 point, fully word-anchored balanced bipolar scale (Satisfaction Assessment).

Secondary outcome measures

Improvement of symptoms determined by M.D. Anderson Symptom Inventory - Acute Myeloid Leukemia / Myelodysplastic Syndromes (MDASI-AML/MDS)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive Care (CBT)Experimental Treatment3 Interventions

Patients undergo CBT consisting of 7 counseling sessions, up to 45 minutes each over the phone.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Cognitive Behavior Therapy

2010

Completed Phase 3

~2630

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,933,105 Total Patients Enrolled

M.D. Anderson Cancer CenterLead Sponsor

2,966 Previous Clinical Trials

1,804,733 Total Patients Enrolled

Sriram YennuPrincipal InvestigatorM.D. Anderson Cancer Center

12 Previous Clinical Trials

1,509 Total Patients Enrolled

Media Library

Cognitive Behavior Therapy Clinical Trial Eligibility Overview. Trial Name: NCT03747757 — Phase 2

Acute Myeloid Leukemia Research Study Groups: Supportive Care (CBT)

Acute Myeloid Leukemia Clinical Trial 2023: Cognitive Behavior Therapy Highlights & Side Effects. Trial Name: NCT03747757 — Phase 2

Cognitive Behavior Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT03747757 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open slots available to participate in this clinical experiment?

"The relevant page of clinicaltrials.gov discloses that this particular research is no longer recruiting patients, having first been posted on the 29th November 2018 and last updated on the 5th December 2022. However, at present there are 3269 other studies actively searching for participants."

Answered by AI

Has the FDA accorded its blessing to the usage of Cognitive Behavioral Therapy (CBT) as a form of Supportive Care?

"Our company has evaluated the safety of Supportive Care (CBT) and assigned it a score of 2, since there are some studies supporting its security but none affirming its efficacy."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue

2018. "Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03747757.

All > Lymphoma